ACC	Adrenocortical carcinoma
BBB	Blood–brain barrier
CAFs	Cancer-associated fibroblasts
CXCR4	Chemokine receptor 4
DOTATOC	DOTA-D-Phe-Tyr3-octreotide
FDG	Fluorodeoxyglucose
GBM	Glioblastoma
HCC	Hepatocellular carcinoma
HNSCC	Head and neck squamous cell carcinoma
IHC	Immunohistochemistry
MIF	Macrophage inhibitory factor
NEC	Neuroendocrine carcinomas
NETs	Neuroendocrine tumours
NF 2	Neurofibromatosis type 2
PDAC	Pancreatic ductal adenocarcinoma
PET	Positron Emission Tomography
PSMA	Prostate specific membrane antigen
OC	Oesophageal cancer
RCC	Renal cell carcinoma
RT	Radiation therapy
SCLC	Small cell lung cancer
SDF-1	Stromal cell-derived factor-1
SSTR	Somatostatin receptor
TAMs	Tumour-associated macrophages
TBR	Tumour to background ratio
TKIs	Tyrosine kinase inhibitors
TME	Tumour microenvironment
TNF	Tumour necrosis factor
VEGF	Vascular endothelial growth factor
VSCC	Vulvar squamous cell carcinoma
VS	Vestibular schwannomas